The aim of this study was to investigate the clinical and genetic characteristics of the prothrombin Ile441Met mutation in relation to IT, providing new insights that may support improved diagnosis and management of thrombophilia in the Chinese population. The gene discussed is F2; the disease is Rare hereditary thrombophilia.